Clinical Cancer Research Journal Issues Research Articles in Dec. 15, 2022 Edition
December 19, 2022
December 19, 2022
PHILADELPHIA, Pennsylvania, Dec. 19 -- Clinical Cancer Research, a journal from the American Association for Cancer Research that presents clinical and translational cancer research studies that bridge the laboratory and the clinic, published research articles on the following topics in its Dec. 15, 2022 edition:
Clinical Trial Brief Reports:
* Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Es . . .
Clinical Trial Brief Reports:
* Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Es . . .